Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric study
Sign Up to like & getrecommendations! Published in 2017 at "Clinical Rheumatology"
DOI: 10.1007/s10067-017-3953-6
Abstract: The current prospective observational study aimed to evaluate the long-term (24 months), real-life effectiveness of ustekinumab in psoriatic arthritis (PsA). Consecutive patients with moderate-severe PsA and active psoriasis who begun ustekinumab treatment were evaluated prospectively (January… read more here.
Keywords: psoriatic arthritis; effectiveness safety; study; safety ustekinumab ... See more keywords
Effectiveness and safety of Ustekinumab for the treatment of Crohn’s disease in real-life experiences: a meta-analysis of observational studies
Sign Up to like & getrecommendations! Published in 2019 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2020.1707800
Abstract: ABSTRACT Background: The aim of this meta-analysis was to estimate the effectiveness and safety of Ustekinumab in Crohn’s disease (CD) reported by observational studies. Research design and methods: PubMed/Medline and Embase were systematically searched through… read more here.
Keywords: effectiveness safety; range; safety ustekinumab; observational studies ... See more keywords
P504 Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with real-world ulcerative colitis: A GETAID multicentre cohort study
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Crohn's and Colitis"
DOI: 10.1093/ecco-jcc/jjab076.626
Abstract: Phase III trials have demonstrated the efficacy and safety of ustekinumab in moderate-to-severe ulcerative colitis (UC), but no real-life long-term data is currently available. From January to September 2019, all consecutive patients with active UC… read more here.
Keywords: colitis; study; ulcerative colitis; week ... See more keywords
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn’s Disease Patients: The SUSTAIN Study
Sign Up to like & getrecommendations! Published in 2022 at "Inflammatory Bowel Diseases"
DOI: 10.1093/ibd/izab357
Abstract: Abstract Background Large real-world-evidence studies are required to confirm the durability of response, effectiveness, and safety of ustekinumab in Crohn’s disease (CD) patients in real-world clinical practice. Methods A retrospective, multicentre study was conducted in… read more here.
Keywords: world; safety ustekinumab; term; effectiveness safety ... See more keywords